Annual Income Statements for Community Healthcare Trust
This table shows Community Healthcare Trust's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.
Quarterly Income Statements for Community Healthcare Trust
This table shows Community Healthcare Trust's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.
Metric |
|
Q3 2022 |
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Net Income / (Loss) Attributable to Common Shareholders |
|
5.67 |
5.24 |
-6.92 |
6.58 |
3.49 |
4.57 |
3.67 |
-10 |
1.75 |
1.83 |
Consolidated Net Income / (Loss) |
|
5.67 |
5.24 |
-6.92 |
6.58 |
3.49 |
4.57 |
3.67 |
-10 |
1.75 |
1.83 |
Net Income / (Loss) Continuing Operations |
|
5.67 |
5.22 |
-6.92 |
6.58 |
3.49 |
4.57 |
3.67 |
-10 |
1.75 |
1.83 |
Total Pre-Tax Income |
|
5.69 |
2.63 |
-6.89 |
6.63 |
3.82 |
4.47 |
3.67 |
-10 |
1.74 |
1.84 |
Total Revenue |
|
22 |
22 |
23 |
24 |
24 |
24 |
24 |
28 |
30 |
11 |
Net Interest Income / (Expense) |
|
-3.02 |
-3.46 |
-3.97 |
-3.39 |
-4.64 |
-4.98 |
-5.06 |
0.31 |
0.21 |
-19 |
Total Interest Income |
|
0.01 |
0.00 |
0.03 |
0.75 |
0.00 |
0.04 |
0.00 |
0.31 |
0.21 |
0.02 |
Total Interest Expense |
|
3.03 |
3.46 |
3.99 |
4.14 |
4.64 |
5.02 |
5.06 |
0.00 |
0.00 |
19 |
Total Non-Interest Income |
|
25 |
25 |
27 |
28 |
29 |
29 |
29 |
28 |
30 |
29 |
Other Service Charges |
|
0.89 |
0.96 |
1.05 |
1.05 |
1.05 |
1.02 |
0.99 |
-0.39 |
0.30 |
0.32 |
Other Non-Interest Income |
|
24 |
24 |
26 |
27 |
28 |
28 |
28 |
28 |
29 |
29 |
Total Non-Interest Expense |
|
16 |
17 |
30 |
18 |
20 |
20 |
21 |
21 |
22 |
21 |
Property & Liability Insurance Claims |
|
4.33 |
4.16 |
4.87 |
4.79 |
5.46 |
5.60 |
5.79 |
5.57 |
5.99 |
5.49 |
Other Operating Expenses |
|
3.76 |
4.15 |
16 |
3.79 |
3.62 |
3.73 |
4.55 |
4.76 |
4.94 |
4.81 |
Depreciation Expense |
|
8.00 |
8.32 |
9.02 |
9.22 |
11 |
10 |
10 |
11 |
11 |
11 |
Basic Earnings per Share |
|
$0.21 |
$0.18 |
($0.32) |
$0.24 |
$0.11 |
$0.17 |
$0.11 |
($0.42) |
$0.04 |
$0.04 |
Weighted Average Basic Shares Outstanding |
|
23.59M |
23.63M |
24.23M |
25.07M |
25.51M |
25.20M |
26.30M |
26.48M |
26.66M |
26.53M |
Diluted Earnings per Share |
|
$0.21 |
$0.18 |
($0.32) |
$0.24 |
$0.11 |
$0.17 |
$0.11 |
($0.42) |
$0.04 |
$0.04 |
Weighted Average Diluted Shares Outstanding |
|
23.59M |
23.63M |
24.23M |
25.07M |
25.51M |
25.20M |
26.30M |
26.48M |
26.66M |
26.53M |
Weighted Average Basic & Diluted Shares Outstanding |
|
25.30M |
26.02M |
26.30M |
26.56M |
27.26M |
27.68M |
27.70M |
28.06M |
28.24M |
28.34M |
Annual Cash Flow Statements for Community Healthcare Trust
This table details how cash moves in and out of Community Healthcare Trust's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.
Metric |
2022 |
2023 |
2024 |
Net Change in Cash & Equivalents |
9.20 |
-7.44 |
-0.25 |
Net Cash From Operating Activities |
60 |
61 |
59 |
Net Cash From Continuing Operating Activities |
60 |
61 |
59 |
Net Income / (Loss) Continuing Operations |
22 |
7.71 |
-3.18 |
Consolidated Net Income / (Loss) |
22 |
7.71 |
-3.18 |
Provision For Loan Losses |
0.00 |
0.00 |
11 |
Depreciation Expense |
32 |
40 |
43 |
Amortization Expense |
0.85 |
13 |
0.93 |
Non-Cash Adjustments to Reconcile Net Income |
6.01 |
4.82 |
8.17 |
Changes in Operating Assets and Liabilities, net |
-0.94 |
-3.39 |
-0.81 |
Net Cash From Investing Activities |
-114 |
-114 |
-93 |
Net Cash From Continuing Investing Activities |
-113 |
-114 |
-92 |
Purchase of Property, Leasehold Improvements and Equipment |
-10 |
-19 |
-25 |
Purchase of Investment Securities |
-106 |
-101 |
-75 |
Sale and/or Maturity of Investments |
3.00 |
6.19 |
7.42 |
Other Investing Activities, net |
0.67 |
- |
0.22 |
Net Cash From Financing Activities |
63 |
45 |
34 |
Net Cash From Continuing Financing Activities |
63 |
45 |
34 |
Issuance of Debt |
150 |
50 |
162 |
Issuance of Common Equity |
21 |
44 |
7.49 |
Repayment of Debt |
-63 |
-0.13 |
-83 |
Payment of Dividends |
-44 |
-48 |
-52 |
Other Financing Activities, Net |
-0.39 |
-1.19 |
-1.01 |
Cash Interest Paid |
11 |
18 |
23 |
Quarterly Cash Flow Statements for Community Healthcare Trust
This table details how cash moves in and out of Community Healthcare Trust's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.
Metric |
|
Q3 2022 |
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Net Change in Cash & Equivalents |
|
0.98 |
8.73 |
-7.44 |
-0.95 |
1.26 |
-0.30 |
0.31 |
-4.21 |
2.10 |
1.55 |
Net Cash From Operating Activities |
|
15 |
15 |
13 |
17 |
18 |
14 |
13 |
17 |
14 |
16 |
Net Cash From Continuing Operating Activities |
|
15 |
15 |
13 |
17 |
18 |
14 |
13 |
17 |
14 |
16 |
Net Income / (Loss) Continuing Operations |
|
5.67 |
5.24 |
-6.92 |
6.58 |
3.49 |
4.57 |
3.67 |
-10 |
1.75 |
1.83 |
Consolidated Net Income / (Loss) |
|
5.67 |
5.24 |
-6.92 |
6.58 |
3.49 |
4.57 |
3.67 |
-10 |
1.75 |
1.83 |
Depreciation Expense |
|
8.00 |
8.32 |
9.02 |
9.22 |
11 |
10 |
10 |
11 |
11 |
11 |
Amortization Expense |
|
0.21 |
0.23 |
12 |
0.24 |
0.05 |
0.19 |
0.22 |
0.17 |
0.25 |
0.29 |
Non-Cash Adjustments to Reconcile Net Income |
|
1.63 |
1.81 |
1.67 |
0.22 |
1.78 |
1.16 |
1.67 |
2.81 |
1.81 |
1.87 |
Changes in Operating Assets and Liabilities, net |
|
-0.16 |
-0.18 |
-3.13 |
0.42 |
1.19 |
-1.87 |
-3.17 |
2.38 |
-0.90 |
0.87 |
Net Cash From Investing Activities |
|
-22 |
-58 |
-29 |
-16 |
-55 |
-14 |
-39 |
-30 |
-14 |
-9.49 |
Net Cash From Continuing Investing Activities |
|
-22 |
-57 |
-29 |
-16 |
-55 |
-14 |
-39 |
-30 |
-14 |
-9.43 |
Purchase of Property, Leasehold Improvements and Equipment |
|
-3.05 |
-3.68 |
-4.14 |
-3.75 |
-3.58 |
-7.52 |
-5.11 |
-7.19 |
-7.19 |
-5.16 |
Purchase of Investment Securities |
|
-20 |
-55 |
-25 |
-17 |
-52 |
-6.90 |
-34 |
-24 |
-8.91 |
-8.42 |
Sale and/or Maturity of Investments |
|
0.75 |
0.75 |
0.75 |
3.78 |
0.79 |
0.87 |
0.87 |
0.75 |
1.72 |
4.09 |
Other Investing Activities, net |
|
- |
- |
- |
- |
- |
- |
0.03 |
0.05 |
0.08 |
0.06 |
Net Cash From Financing Activities |
|
7.73 |
51 |
8.44 |
-1.15 |
39 |
-1.04 |
26 |
9.32 |
2.64 |
-4.63 |
Net Cash From Continuing Financing Activities |
|
7.73 |
51 |
8.44 |
-1.15 |
39 |
-1.04 |
26 |
9.32 |
2.64 |
-4.63 |
Issuance of Debt |
|
19 |
105 |
12 |
3.00 |
33 |
2.00 |
39 |
20 |
16 |
87 |
Repayment of Debt |
|
-0.03 |
-63 |
-0.03 |
-0.03 |
-0.03 |
-0.03 |
-0.03 |
-4.79 |
- |
-78 |
Payment of Dividends |
|
-11 |
-11 |
-12 |
-12 |
-12 |
-12 |
-13 |
-13 |
-13 |
-13 |
Other Financing Activities, Net |
|
-0.05 |
-0.21 |
-0.10 |
-1.01 |
-0.04 |
-0.05 |
-0.61 |
-0.06 |
-0.29 |
-0.05 |
Cash Interest Paid |
|
2.61 |
3.21 |
4.06 |
4.16 |
2.17 |
7.34 |
4.79 |
5.91 |
6.23 |
6.14 |
Annual Balance Sheets for Community Healthcare Trust
This table presents Community Healthcare Trust's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.
Metric |
2022 |
2023 |
2024 |
Total Assets |
876 |
945 |
993 |
Cash and Due from Banks |
11 |
3.49 |
4.38 |
Restricted Cash |
0.84 |
1.14 |
0.00 |
Loans and Leases, Net of Allowance |
0.00 |
0.00 |
0.00 |
Premises and Equipment, Net |
778 |
849 |
903 |
Other Assets |
87 |
91 |
85 |
Total Liabilities & Shareholders' Equity |
876 |
945 |
993 |
Total Liabilities |
380 |
432 |
517 |
Other Short-Term Payables |
11 |
12 |
14 |
Long-Term Debt |
353 |
403 |
486 |
Other Long-Term Liabilities |
15 |
17 |
16 |
Commitments & Contingencies |
0.00 |
0.00 |
0.00 |
Total Equity & Noncontrolling Interests |
497 |
513 |
476 |
Total Preferred & Common Equity |
497 |
513 |
476 |
Preferred Stock |
0.00 |
0.00 |
0.00 |
Total Common Equity |
497 |
513 |
476 |
Common Stock |
625 |
688 |
705 |
Retained Earnings |
-151 |
-192 |
-246 |
Accumulated Other Comprehensive Income / (Loss) |
23 |
16 |
18 |
Quarterly Balance Sheets for Community Healthcare Trust
This table presents Community Healthcare Trust's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.
Metric |
|
Q3 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Total Assets |
|
812 |
886 |
900 |
955 |
983 |
983 |
982 |
Cash and Due from Banks |
|
2.66 |
3.67 |
2.63 |
3.89 |
3.81 |
0.73 |
2.84 |
Restricted Cash |
|
0.68 |
0.96 |
1.05 |
1.05 |
1.14 |
0.00 |
0.00 |
Loans and Leases, Net of Allowance |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Premises and Equipment, Net |
|
730 |
797 |
805 |
852 |
880 |
899 |
903 |
Other Assets |
|
79 |
85 |
92 |
98 |
98 |
84 |
76 |
Total Liabilities & Shareholders' Equity |
|
812 |
886 |
900 |
955 |
983 |
983 |
982 |
Total Liabilities |
|
333 |
392 |
395 |
433 |
471 |
485 |
505 |
Other Short-Term Payables |
|
8.14 |
10 |
11 |
15 |
12 |
12 |
14 |
Long-Term Debt |
|
311 |
365 |
368 |
401 |
442 |
458 |
474 |
Other Long-Term Liabilities |
|
15 |
16 |
16 |
16 |
17 |
16 |
16 |
Commitments & Contingencies |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Total Equity & Noncontrolling Interests |
|
478 |
495 |
505 |
522 |
512 |
498 |
477 |
Total Preferred & Common Equity |
|
478 |
495 |
505 |
522 |
512 |
498 |
477 |
Preferred Stock |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Total Common Equity |
|
478 |
495 |
505 |
522 |
512 |
498 |
477 |
Common Stock |
|
602 |
649 |
657 |
677 |
691 |
700 |
702 |
Retained Earnings |
|
-145 |
-170 |
-175 |
-184 |
-201 |
-224 |
-235 |
Accumulated Other Comprehensive Income / (Loss) |
|
21 |
16 |
23 |
29 |
21 |
21 |
10 |
Annual Metrics And Ratios for Community Healthcare Trust
This table displays calculated financial ratios and metrics derived from Community Healthcare Trust's official financial filings.
Metric |
2022 |
2023 |
2024 |
Growth Metrics |
- |
- |
- |
Revenue Growth |
7.21% |
11.64% |
-3.40% |
EBITDA Growth |
2.99% |
9.06% |
-32.75% |
EBIT Growth |
-1.61% |
-63.64% |
-139.66% |
NOPAT Growth |
-1.80% |
-64.97% |
-128.87% |
Net Income Growth |
-2.10% |
-64.97% |
-141.24% |
EPS Growth |
-6.90% |
-75.31% |
-215.00% |
Operating Cash Flow Growth |
6.98% |
1.83% |
-4.08% |
Free Cash Flow Firm Growth |
-58.75% |
41.05% |
19.25% |
Invested Capital Growth |
16.77% |
7.85% |
4.95% |
Revenue Q/Q Growth |
1.69% |
2.41% |
-12.70% |
EBITDA Q/Q Growth |
-0.31% |
1.86% |
-25.01% |
EBIT Q/Q Growth |
-2.99% |
-9.01% |
-113.96% |
NOPAT Q/Q Growth |
9.37% |
24.64% |
-605.32% |
Net Income Q/Q Growth |
-3.82% |
-8.00% |
-613.23% |
EPS Q/Q Growth |
-6.90% |
-4.76% |
-130.00% |
Operating Cash Flow Q/Q Growth |
0.69% |
-1.79% |
2.39% |
Free Cash Flow Firm Q/Q Growth |
-100.50% |
53.93% |
-71.98% |
Invested Capital Q/Q Growth |
7.67% |
-0.76% |
1.16% |
Profitability Metrics |
- |
- |
- |
EBITDA Margin |
64.34% |
62.86% |
43.76% |
EBIT Margin |
25.69% |
8.37% |
-3.43% |
Profit (Net Income) Margin |
25.64% |
8.05% |
-3.43% |
Tax Burden Percent |
99.81% |
96.18% |
100.00% |
Interest Burden Percent |
100.00% |
100.00% |
100.00% |
Effective Tax Rate |
0.19% |
3.82% |
0.00% |
Return on Invested Capital (ROIC) |
2.79% |
0.87% |
-0.24% |
ROIC Less NNEP Spread (ROIC-NNEP) |
2.79% |
0.87% |
-0.45% |
Return on Net Nonoperating Assets (RNNOA) |
1.80% |
0.65% |
-0.41% |
Return on Equity (ROE) |
4.59% |
1.53% |
-0.64% |
Cash Return on Invested Capital (CROIC) |
-12.68% |
-6.68% |
-5.07% |
Operating Return on Assets (OROA) |
2.71% |
0.88% |
-0.33% |
Return on Assets (ROA) |
2.70% |
0.85% |
-0.33% |
Return on Common Equity (ROCE) |
4.59% |
1.53% |
-0.64% |
Return on Equity Simple (ROE_SIMPLE) |
4.43% |
1.50% |
-0.67% |
Net Operating Profit after Tax (NOPAT) |
22 |
7.71 |
-2.23 |
NOPAT Margin |
25.64% |
8.05% |
-2.40% |
Net Nonoperating Expense Percent (NNEP) |
0.00% |
0.00% |
0.21% |
SG&A Expenses to Revenue |
0.00% |
0.00% |
0.00% |
Operating Expenses to Revenue |
74.31% |
91.63% |
91.56% |
Earnings before Interest and Taxes (EBIT) |
22 |
8.02 |
-3.18 |
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
55 |
60 |
41 |
Valuation Ratios |
- |
- |
- |
Price to Book Value (P/BV) |
1.59 |
1.30 |
1.14 |
Price to Tangible Book Value (P/TBV) |
1.59 |
1.30 |
1.14 |
Price to Revenue (P/Rev) |
9.18 |
6.96 |
5.86 |
Price to Earnings (P/E) |
35.82 |
86.48 |
0.00 |
Dividend Yield |
5.66% |
7.38% |
9.60% |
Earnings Yield |
2.79% |
1.16% |
0.00% |
Enterprise Value to Invested Capital (EV/IC) |
1.33 |
1.16 |
1.06 |
Enterprise Value to Revenue (EV/Rev) |
13.15 |
11.12 |
11.06 |
Enterprise Value to EBITDA (EV/EBITDA) |
20.44 |
17.69 |
25.27 |
Enterprise Value to EBIT (EV/EBIT) |
51.20 |
132.88 |
0.00 |
Enterprise Value to NOPAT (EV/NOPAT) |
51.30 |
138.15 |
0.00 |
Enterprise Value to Operating Cash Flow (EV/OCF) |
18.74 |
17.36 |
17.39 |
Enterprise Value to Free Cash Flow (EV/FCFF) |
0.00 |
0.00 |
0.00 |
Leverage & Solvency |
- |
- |
- |
Debt to Equity |
0.71 |
0.79 |
1.02 |
Long-Term Debt to Equity |
0.71 |
0.79 |
1.02 |
Financial Leverage |
0.65 |
0.75 |
0.90 |
Leverage Ratio |
1.70 |
1.80 |
1.96 |
Compound Leverage Factor |
1.70 |
1.80 |
1.96 |
Debt to Total Capital |
41.54% |
44.00% |
50.52% |
Short-Term Debt to Total Capital |
0.00% |
0.00% |
0.00% |
Long-Term Debt to Total Capital |
41.54% |
44.00% |
50.52% |
Preferred Equity to Total Capital |
0.00% |
0.00% |
0.00% |
Noncontrolling Interests to Total Capital |
0.00% |
0.00% |
0.00% |
Common Equity to Total Capital |
58.46% |
56.00% |
49.48% |
Debt to EBITDA |
6.39 |
6.69 |
11.99 |
Net Debt to EBITDA |
6.17 |
6.62 |
11.88 |
Long-Term Debt to EBITDA |
6.39 |
6.69 |
11.99 |
Debt to NOPAT |
16.03 |
52.28 |
-218.24 |
Net Debt to NOPAT |
15.48 |
51.68 |
-216.27 |
Long-Term Debt to NOPAT |
16.03 |
52.28 |
-218.24 |
Noncontrolling Interest Sharing Ratio |
0.00% |
0.00% |
0.00% |
Liquidity Ratios |
- |
- |
- |
Cash Flow Metrics |
- |
- |
- |
Free Cash Flow to Firm (FCFF) |
-100 |
-59 |
-48 |
Operating Cash Flow to CapEx |
580.96% |
323.39% |
238.93% |
Free Cash Flow to Firm to Interest Expense |
-8.43 |
-3.32 |
-2.01 |
Operating Cash Flow to Interest Expense |
5.08 |
3.45 |
2.48 |
Operating Cash Flow Less CapEx to Interest Expense |
4.20 |
2.38 |
1.44 |
Efficiency Ratios |
- |
- |
- |
Asset Turnover |
0.11 |
0.11 |
0.10 |
Fixed Asset Turnover |
0.12 |
0.12 |
0.11 |
Capital & Investment Metrics |
- |
- |
- |
Invested Capital |
850 |
917 |
962 |
Invested Capital Turnover |
0.11 |
0.11 |
0.10 |
Increase / (Decrease) in Invested Capital |
122 |
67 |
45 |
Enterprise Value (EV) |
1,130 |
1,066 |
1,024 |
Market Capitalization |
789 |
667 |
543 |
Book Value per Share |
$19.64 |
$18.83 |
$16.85 |
Tangible Book Value per Share |
$19.64 |
$18.83 |
$16.85 |
Total Capital |
850 |
917 |
962 |
Total Debt |
353 |
403 |
486 |
Total Long-Term Debt |
353 |
403 |
486 |
Net Debt |
341 |
399 |
482 |
Capital Expenditures (CapEx) |
10 |
19 |
25 |
Net Nonoperating Expense (NNE) |
0.00 |
0.00 |
0.95 |
Net Nonoperating Obligations (NNO) |
353 |
403 |
486 |
Total Depreciation and Amortization (D&A) |
33 |
52 |
44 |
Earnings Adjustments |
- |
- |
- |
Adjusted Basic Earnings per Share |
$0.81 |
$0.20 |
($0.23) |
Adjusted Weighted Average Basic Shares Outstanding |
23.63M |
25.20M |
26.53M |
Adjusted Diluted Earnings per Share |
$0.81 |
$0.20 |
($0.23) |
Adjusted Weighted Average Diluted Shares Outstanding |
23.63M |
25.20M |
26.53M |
Adjusted Basic & Diluted Earnings per Share |
$0.00 |
$0.00 |
$0.00 |
Adjusted Weighted Average Basic & Diluted Shares Outstanding |
26.02M |
27.68M |
28.34M |
Normalized Net Operating Profit after Tax (NOPAT) |
22 |
7.81 |
-2.14 |
Normalized NOPAT Margin |
25.64% |
8.15% |
-2.31% |
Pre Tax Income Margin |
25.69% |
8.37% |
-3.43% |
Debt Service Ratios |
- |
- |
- |
EBIT to Interest Expense |
1.86 |
0.45 |
-0.13 |
NOPAT to Interest Expense |
1.85 |
0.43 |
-0.09 |
EBIT Less CapEx to Interest Expense |
0.98 |
-0.62 |
-1.17 |
NOPAT Less CapEx to Interest Expense |
0.98 |
-0.63 |
-1.13 |
Payout Ratios |
- |
- |
- |
Dividend Payout Ratio |
202.03% |
623.01% |
-1,625.21% |
Augmented Payout Ratio |
202.03% |
623.01% |
-1,625.21% |
Quarterly Metrics And Ratios for Community Healthcare Trust
This table displays calculated financial ratios and metrics derived from Community Healthcare Trust's official financial filings.
Metric |
|
Q3 2022 |
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Growth Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Revenue Growth |
|
6.44% |
6.98% |
11.28% |
14.38% |
10.61% |
10.33% |
4.58% |
13.94% |
23.85% |
-55.80% |
EBITDA Growth |
|
3.67% |
-1.22% |
3.88% |
15.92% |
8.40% |
7.96% |
-0.36% |
-59.49% |
27.22% |
-95.40% |
EBIT Growth |
|
5.46% |
-11.45% |
-225.06% |
18.34% |
-33.00% |
-15.10% |
153.22% |
-167.01% |
109.62% |
-332.97% |
NOPAT Growth |
|
-30.31% |
272.56% |
-159.16% |
17.45% |
-36.65% |
69.51% |
176.02% |
-147.27% |
122.51% |
-58.86% |
Net Income Growth |
|
5.96% |
-14.31% |
-225.31% |
17.78% |
-38.45% |
-12.81% |
152.95% |
-258.54% |
-49.91% |
-59.89% |
EPS Growth |
|
5.00% |
-25.00% |
-252.38% |
14.29% |
-47.62% |
-5.56% |
134.38% |
-275.00% |
-63.64% |
-76.47% |
Operating Cash Flow Growth |
|
15.85% |
2.77% |
-11.83% |
10.31% |
15.41% |
-7.26% |
-0.43% |
0.32% |
-21.85% |
9.60% |
Free Cash Flow Firm Growth |
|
47.30% |
-40.95% |
-459.26% |
-134.76% |
-102.95% |
47.89% |
26.61% |
16.77% |
85.16% |
29.99% |
Invested Capital Growth |
|
9.74% |
16.77% |
16.04% |
14.22% |
17.01% |
7.85% |
10.98% |
9.38% |
2.97% |
4.95% |
Revenue Q/Q Growth |
|
2.05% |
0.44% |
6.07% |
5.21% |
-1.32% |
0.18% |
0.54% |
14.63% |
7.27% |
-64.25% |
EBITDA Q/Q Growth |
|
0.18% |
-0.74% |
2.85% |
13.34% |
-6.31% |
-1.14% |
-6.36% |
-53.92% |
194.20% |
-96.42% |
EBIT Q/Q Growth |
|
1.68% |
-7.64% |
-230.96% |
196.22% |
-42.43% |
17.04% |
-21.50% |
-221.17% |
280.07% |
-230.07% |
NOPAT Q/Q Growth |
|
1.30% |
-53.57% |
-283.03% |
236.43% |
-45.36% |
24.23% |
-21.50% |
-184.82% |
357.25% |
-77.03% |
Net Income Q/Q Growth |
|
1.59% |
-7.67% |
-232.15% |
195.02% |
-46.91% |
30.78% |
-19.75% |
-384.50% |
116.77% |
4.75% |
EPS Q/Q Growth |
|
0.00% |
-14.29% |
-277.78% |
175.00% |
-54.17% |
54.55% |
-35.29% |
-481.82% |
109.52% |
0.00% |
Operating Cash Flow Q/Q Growth |
|
1.55% |
0.38% |
-17.60% |
31.33% |
6.24% |
-19.33% |
-11.54% |
32.32% |
-17.24% |
13.14% |
Free Cash Flow Firm Q/Q Growth |
|
-47.86% |
-85.57% |
-3.49% |
17.33% |
-27.83% |
52.36% |
-46.26% |
6.25% |
77.21% |
-124.77% |
Invested Capital Q/Q Growth |
|
3.21% |
7.67% |
1.15% |
1.61% |
5.73% |
-0.76% |
4.09% |
0.15% |
-0.47% |
1.16% |
Profitability Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
EBITDA Margin |
|
63.83% |
63.08% |
61.16% |
65.89% |
62.55% |
61.72% |
58.27% |
23.43% |
64.25% |
6.43% |
EBIT Margin |
|
26.14% |
24.03% |
-29.67% |
27.14% |
15.83% |
18.50% |
15.10% |
-15.96% |
26.80% |
-97.49% |
Profit (Net Income) Margin |
|
26.04% |
23.94% |
-29.82% |
26.93% |
14.49% |
18.92% |
15.10% |
-37.48% |
5.86% |
17.17% |
Tax Burden Percent |
|
99.63% |
198.86% |
100.51% |
99.25% |
91.53% |
102.28% |
100.00% |
100.00% |
100.29% |
99.73% |
Interest Burden Percent |
|
100.00% |
50.09% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
234.79% |
21.81% |
-17.66% |
Effective Tax Rate |
|
0.37% |
0.00% |
0.00% |
0.75% |
5.79% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Return on Invested Capital (ROIC) |
|
2.92% |
1.31% |
-2.29% |
3.00% |
1.63% |
2.01% |
1.61% |
-1.23% |
3.03% |
1.70% |
ROIC Less NNEP Spread (ROIC-NNEP) |
|
2.92% |
2.15% |
-2.95% |
3.00% |
1.60% |
2.03% |
1.61% |
-3.00% |
1.60% |
1.70% |
Return on Net Nonoperating Assets (RNNOA) |
|
1.76% |
1.39% |
-1.94% |
2.02% |
1.14% |
1.52% |
1.30% |
-2.47% |
1.40% |
1.53% |
Return on Equity (ROE) |
|
4.68% |
2.70% |
-4.23% |
5.03% |
2.77% |
3.53% |
2.91% |
-3.69% |
4.44% |
3.22% |
Cash Return on Invested Capital (CROIC) |
|
-6.62% |
-12.68% |
-13.97% |
-12.29% |
-14.95% |
-6.68% |
-8.38% |
-8.78% |
-2.96% |
-5.07% |
Operating Return on Assets (OROA) |
|
2.83% |
2.53% |
-3.18% |
2.94% |
1.68% |
1.95% |
1.57% |
-1.70% |
2.94% |
-9.32% |
Return on Assets (ROA) |
|
2.82% |
2.52% |
-3.19% |
2.92% |
1.54% |
1.99% |
1.57% |
-3.99% |
0.64% |
1.64% |
Return on Common Equity (ROCE) |
|
4.68% |
2.70% |
-4.23% |
5.03% |
2.77% |
3.53% |
2.91% |
-3.69% |
4.44% |
3.22% |
Return on Equity Simple (ROE_SIMPLE) |
|
4.78% |
0.00% |
1.94% |
2.09% |
1.61% |
0.00% |
3.58% |
0.26% |
-0.09% |
0.00% |
Net Operating Profit after Tax (NOPAT) |
|
5.67 |
2.63 |
-4.82 |
6.58 |
3.59 |
4.47 |
3.67 |
-3.11 |
8.00 |
1.84 |
NOPAT Margin |
|
26.04% |
12.04% |
-20.77% |
26.93% |
14.91% |
18.50% |
15.10% |
-11.17% |
26.80% |
17.22% |
Net Nonoperating Expense Percent (NNEP) |
|
0.00% |
-0.84% |
0.66% |
0.00% |
0.03% |
-0.03% |
0.00% |
1.77% |
1.43% |
0.00% |
SG&A Expenses to Revenue |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Operating Expenses to Revenue |
|
73.86% |
75.97% |
129.67% |
72.86% |
84.17% |
81.50% |
84.90% |
76.43% |
73.20% |
197.49% |
Earnings before Interest and Taxes (EBIT) |
|
5.69 |
5.26 |
-6.89 |
6.63 |
3.82 |
4.47 |
3.67 |
-4.44 |
8.00 |
-10 |
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
|
14 |
14 |
14 |
16 |
15 |
15 |
14 |
6.52 |
19 |
0.69 |
Valuation Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Price to Book Value (P/BV) |
|
1.51 |
1.59 |
1.74 |
1.57 |
1.40 |
1.30 |
1.35 |
1.27 |
1.07 |
1.14 |
Price to Tangible Book Value (P/TBV) |
|
1.51 |
1.59 |
1.74 |
1.57 |
1.40 |
1.30 |
1.35 |
1.27 |
1.07 |
1.14 |
Price to Revenue (P/Rev) |
|
8.58 |
9.18 |
9.74 |
8.69 |
7.80 |
6.96 |
7.15 |
6.30 |
4.80 |
5.86 |
Price to Earnings (P/E) |
|
31.64 |
35.82 |
89.79 |
75.12 |
87.07 |
86.48 |
37.65 |
451.84 |
0.00 |
0.00 |
Dividend Yield |
|
6.08% |
5.66% |
5.37% |
5.92% |
6.53% |
7.38% |
7.14% |
8.00% |
10.11% |
9.60% |
Earnings Yield |
|
3.16% |
2.79% |
1.11% |
1.33% |
1.15% |
1.16% |
2.66% |
0.22% |
0.00% |
0.00% |
Enterprise Value to Invested Capital (EV/IC) |
|
1.31 |
1.33 |
1.42 |
1.33 |
1.22 |
1.16 |
1.18 |
1.14 |
1.03 |
1.06 |
Enterprise Value to Revenue (EV/Rev) |
|
12.22 |
13.15 |
13.83 |
12.69 |
12.03 |
11.12 |
11.66 |
10.85 |
9.24 |
11.06 |
Enterprise Value to EBITDA (EV/EBITDA) |
|
18.62 |
20.44 |
21.87 |
19.97 |
19.04 |
17.69 |
23.30 |
21.81 |
18.14 |
25.27 |
Enterprise Value to EBIT (EV/EBIT) |
|
45.38 |
51.20 |
126.21 |
108.31 |
127.79 |
132.88 |
60.53 |
58.53 |
43.01 |
0.00 |
Enterprise Value to NOPAT (EV/NOPAT) |
|
51.25 |
51.30 |
173.27 |
143.55 |
182.00 |
138.15 |
61.42 |
672.23 |
0.00 |
0.00 |
Enterprise Value to Operating Cash Flow (EV/OCF) |
|
17.24 |
18.74 |
20.83 |
19.26 |
18.02 |
17.36 |
18.43 |
17.74 |
17.04 |
17.39 |
Enterprise Value to Free Cash Flow (EV/FCFF) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Leverage & Solvency |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Debt to Equity |
|
0.65 |
0.71 |
0.74 |
0.73 |
0.77 |
0.79 |
0.86 |
0.92 |
0.99 |
1.02 |
Long-Term Debt to Equity |
|
0.65 |
0.71 |
0.74 |
0.73 |
0.77 |
0.79 |
0.86 |
0.92 |
0.99 |
1.02 |
Financial Leverage |
|
0.60 |
0.65 |
0.66 |
0.67 |
0.71 |
0.75 |
0.80 |
0.82 |
0.88 |
0.90 |
Leverage Ratio |
|
1.66 |
1.70 |
1.71 |
1.72 |
1.77 |
1.80 |
1.86 |
1.88 |
1.94 |
1.96 |
Compound Leverage Factor |
|
1.66 |
0.85 |
1.71 |
1.72 |
1.77 |
1.80 |
1.86 |
4.41 |
0.42 |
-0.35 |
Debt to Total Capital |
|
39.38% |
41.54% |
42.47% |
42.15% |
43.44% |
44.00% |
46.37% |
47.90% |
49.82% |
50.52% |
Short-Term Debt to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Long-Term Debt to Total Capital |
|
39.38% |
41.54% |
42.47% |
42.15% |
43.44% |
44.00% |
46.37% |
47.90% |
49.82% |
50.52% |
Preferred Equity to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Noncontrolling Interests to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Common Equity to Total Capital |
|
60.62% |
58.46% |
57.53% |
57.85% |
56.56% |
56.00% |
53.63% |
52.10% |
50.18% |
49.48% |
Debt to EBITDA |
|
5.61 |
6.39 |
6.54 |
6.35 |
6.78 |
6.69 |
9.12 |
9.16 |
8.77 |
11.99 |
Net Debt to EBITDA |
|
5.55 |
6.17 |
6.46 |
6.28 |
6.70 |
6.62 |
9.02 |
9.15 |
8.71 |
11.88 |
Long-Term Debt to EBITDA |
|
5.61 |
6.39 |
6.54 |
6.35 |
6.78 |
6.69 |
9.12 |
9.16 |
8.77 |
11.99 |
Debt to NOPAT |
|
15.44 |
16.03 |
51.85 |
45.63 |
64.82 |
52.28 |
24.04 |
282.48 |
-1,500.53 |
-218.24 |
Net Debt to NOPAT |
|
15.27 |
15.48 |
51.19 |
45.17 |
64.03 |
51.68 |
23.77 |
282.03 |
-1,491.54 |
-216.27 |
Long-Term Debt to NOPAT |
|
15.44 |
16.03 |
51.85 |
45.63 |
64.82 |
52.28 |
24.04 |
282.48 |
-1,500.53 |
-218.24 |
Noncontrolling Interest Sharing Ratio |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Liquidity Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Cash Flow Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Free Cash Flow to Firm (FCFF) |
|
-64 |
-119 |
-124 |
-102 |
-131 |
-62 |
-91 |
-85 |
-19 |
-44 |
Operating Cash Flow to CapEx |
|
503.31% |
418.98% |
306.86% |
445.17% |
495.30% |
190.05% |
247.27% |
232.83% |
192.69% |
303.51% |
Free Cash Flow to Firm to Interest Expense |
|
-21.26 |
-34.48 |
-30.97 |
-24.68 |
-28.15 |
-12.40 |
-17.92 |
0.00 |
0.00 |
-2.34 |
Operating Cash Flow to Interest Expense |
|
5.07 |
4.45 |
3.18 |
4.03 |
3.82 |
2.85 |
2.50 |
0.00 |
0.00 |
0.84 |
Operating Cash Flow Less CapEx to Interest Expense |
|
4.06 |
3.39 |
2.14 |
3.12 |
3.05 |
1.35 |
1.49 |
0.00 |
0.00 |
0.56 |
Efficiency Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Asset Turnover |
|
0.11 |
0.11 |
0.11 |
0.11 |
0.11 |
0.11 |
0.10 |
0.11 |
0.11 |
0.10 |
Fixed Asset Turnover |
|
0.08 |
0.12 |
0.12 |
0.12 |
0.12 |
0.12 |
0.12 |
0.12 |
0.12 |
0.11 |
Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Invested Capital |
|
789 |
850 |
860 |
873 |
923 |
917 |
954 |
955 |
951 |
962 |
Invested Capital Turnover |
|
0.11 |
0.11 |
0.11 |
0.11 |
0.11 |
0.11 |
0.11 |
0.11 |
0.11 |
0.10 |
Increase / (Decrease) in Invested Capital |
|
70 |
122 |
119 |
109 |
134 |
67 |
94 |
82 |
27 |
45 |
Enterprise Value (EV) |
|
1,032 |
1,130 |
1,220 |
1,158 |
1,126 |
1,066 |
1,130 |
1,089 |
980 |
1,024 |
Market Capitalization |
|
724 |
789 |
860 |
794 |
730 |
667 |
693 |
632 |
509 |
543 |
Book Value per Share |
|
$19.06 |
$19.64 |
$19.00 |
$19.21 |
$19.67 |
$18.83 |
$19.46 |
$17.97 |
$17.01 |
$16.85 |
Tangible Book Value per Share |
|
$19.06 |
$19.64 |
$19.00 |
$19.21 |
$19.67 |
$18.83 |
$19.46 |
$17.97 |
$17.01 |
$16.85 |
Total Capital |
|
789 |
850 |
860 |
873 |
923 |
917 |
954 |
955 |
951 |
962 |
Total Debt |
|
311 |
353 |
365 |
368 |
401 |
403 |
442 |
458 |
474 |
486 |
Total Long-Term Debt |
|
311 |
353 |
365 |
368 |
401 |
403 |
442 |
458 |
474 |
486 |
Net Debt |
|
307 |
341 |
360 |
364 |
396 |
399 |
437 |
457 |
471 |
482 |
Capital Expenditures (CapEx) |
|
3.05 |
3.68 |
4.14 |
3.75 |
3.58 |
7.52 |
5.11 |
7.19 |
7.19 |
5.16 |
Net Nonoperating Expense (NNE) |
|
0.00 |
-2.60 |
2.10 |
0.00 |
0.10 |
-0.10 |
0.00 |
7.32 |
6.25 |
0.01 |
Net Nonoperating Obligations (NNO) |
|
311 |
353 |
365 |
368 |
401 |
403 |
442 |
458 |
474 |
486 |
Total Depreciation and Amortization (D&A) |
|
8.21 |
8.54 |
21 |
9.46 |
11 |
10 |
10 |
11 |
11 |
11 |
Earnings Adjustments |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Adjusted Basic Earnings per Share |
|
$0.21 |
$0.18 |
($0.32) |
$0.24 |
$0.11 |
$0.17 |
$0.11 |
($0.42) |
$0.04 |
$0.04 |
Adjusted Weighted Average Basic Shares Outstanding |
|
23.59M |
23.63M |
24.23M |
25.07M |
25.51M |
25.20M |
26.30M |
26.48M |
26.66M |
26.53M |
Adjusted Diluted Earnings per Share |
|
$0.21 |
$0.18 |
($0.32) |
$0.24 |
$0.11 |
$0.17 |
$0.11 |
($0.42) |
$0.04 |
$0.04 |
Adjusted Weighted Average Diluted Shares Outstanding |
|
23.59M |
23.63M |
24.23M |
25.07M |
25.51M |
25.20M |
26.30M |
26.48M |
26.66M |
26.53M |
Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
25.30M |
26.02M |
26.30M |
26.56M |
27.26M |
27.68M |
27.70M |
28.06M |
28.24M |
28.34M |
Normalized Net Operating Profit after Tax (NOPAT) |
|
5.67 |
1.84 |
-4.82 |
6.58 |
3.59 |
3.13 |
2.57 |
-3.01 |
5.60 |
1.29 |
Normalized NOPAT Margin |
|
26.04% |
8.43% |
-20.77% |
26.93% |
14.91% |
12.95% |
10.57% |
-10.82% |
18.76% |
12.05% |
Pre Tax Income Margin |
|
26.14% |
12.04% |
-29.67% |
27.14% |
15.83% |
18.50% |
15.10% |
-37.48% |
5.84% |
17.22% |
Debt Service Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
EBIT to Interest Expense |
|
1.88 |
1.52 |
-1.73 |
1.60 |
0.82 |
0.89 |
0.72 |
0.00 |
0.00 |
-0.56 |
NOPAT to Interest Expense |
|
1.87 |
0.76 |
-1.21 |
1.59 |
0.77 |
0.89 |
0.72 |
0.00 |
0.00 |
0.10 |
EBIT Less CapEx to Interest Expense |
|
0.87 |
0.46 |
-2.76 |
0.70 |
0.05 |
-0.61 |
-0.29 |
0.00 |
0.00 |
-0.83 |
NOPAT Less CapEx to Interest Expense |
|
0.87 |
-0.30 |
-2.24 |
0.68 |
0.00 |
-0.61 |
-0.29 |
0.00 |
0.00 |
-0.18 |
Payout Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Dividend Payout Ratio |
|
192.50% |
202.03% |
471.76% |
435.05% |
559.51% |
623.01% |
268.28% |
3,858.67% |
-11,430.72% |
-1,625.21% |
Augmented Payout Ratio |
|
192.50% |
202.03% |
471.76% |
435.05% |
559.51% |
623.01% |
268.28% |
3,858.67% |
-11,430.72% |
-1,625.21% |
Key Financial Trends
Community Healthcare Trust (NYSE: CHCT) has displayed several financial trends over the last four years based on the quarterly financial statements from Q3 2022 through Q4 2024.
Positive Points:
- Consistent growth in total assets, increasing from approximately $811.9 million in Q3 2022 to near $982.7 million by Q1 2024, indicating asset expansion.
- Stable levels of depreciation and amortization expenses with depreciation around $9-11 million quarterly, reflecting steady property and equipment utilization.
- Steady non-interest income, consistently in the $25 million to $29 million range quarterly, providing diversification from interest-based income.
- Generally positive consolidated net income in Q3 and Q4 of recent years (e.g., $4.57 million in Q4 2023 and $1.83 million in Q4 2024), showing profitability improvement after some previous losses.
- Operating cash flow remains strong, with net cash from continuing operating activities around $12-17 million each quarter, supporting ongoing operations and investment.
- Issuance of debt capital has supported investment and operations, with large issuances such as $87 million in Q4 2024, strengthening liquidity availability.
- Dividends paid have been stable or growing slightly, indicating management confidence in steady cash flow (e.g., dividends per share increased from about $0.44 in 2022 to $0.46 in 2024).
- Total common equity has grown from roughly $478 million in Q3 2022 to about $511 million by Q1 2024, indicating strengthened shareholder equity base.
Neutral Points:
- Net interest income is often negative or close to zero, resulting from higher interest expenses relative to interest income, which is typical in REITs focusing on real estate investments financed via debt.
- Total liabilities have increased moderately from $333 million in Q3 2022 to approximately $471 million in Q1 2024, tracking growth in long-term debt to fund property assets.
Negative Points:
- Volatile net income with some quarters showing losses, particularly in early 2023 (e.g., Q1 2023 net loss of over $6.9 million), which may concern investors regarding earnings stability.
- Substantial and ongoing investments expenditures, indicated by large negative cash flows from investing activities sometimes exceeding $30 million quarterly, which can strain liquidity if not matched by financing.
- High interest expense on long-term debt, consistently over $4 million to $6 million per quarter, creating pressure on net interest margin and earnings.
- Other operating expenses and property & liability insurance claims remain significant, with total non-interest expenses around $16-21 million quarterly, impacting profitability.
Summary: Over the last four years, Community Healthcare Trust has steadily expanded its asset base and equity capital while maintaining consistent operating cash flows and dividend payments. However, its profitability has faced challenges due to high interest expenses and significant operating costs, leading to some quarters of net loss. The company’s reliance on debt financing and large investing outlays highlight the importance of monitoring interest costs and capital allocation efficiency. Overall, CHCT shows signs of recovery and growth, but investors should be cautious about earnings volatility and operating leverage risks.
10/09/25 03:55 AM ETAI Generated. May Contain Errors.